![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Hao Wang & Xulu Lei. (2023) Acupuncture for Women with Overactive Bladder: Perspective of Traditional Chinese Medicine and Related Mechanism. International Journal of General Medicine 16, pages 1137-1148.
Read now
Read now
Umberto Leone Roberti Maggiore, Carolina Scala, Pier Luigi Venturini & Simone Ferrero. (2013)
Imidafenacin for the treatment of overactive bladder. Expert Opinion on Pharmacotherapy 14:10, pages 1383-1397.
Read now
Read now
Articles from other publishers (17)
Reginald Ononye & Luke Mistry. (2023) Aggressive Bladder Tumour Following Clam Ileocystoplasty: A Rare Long-Term Complication. Cureus.
Crossref
Crossref
Limin Liao, Qinggang Liu, Huiling Cong, Zhihui Xu, Enhui Li, Zhiliang Weng, Haihong Jiang, Ben Liu, Xiao Huang, Shujie Xia, Wei Wen, Juan Wu, Guowei Shi, Yang Wang, Peijun Li, Yang Yu, Zujun Fang, Jie Zheng, Ye Tian, Donghao Shang, Hanzhong Li, Zhongming Huang, Liqun Zhou, Yunxiang Xiao, Yaoguang Zhang, Jianlong Wang, Xiaodong Zhang, Peng Zhang, Dongwen Wang, Xuhui Zhang, Keji Xie, Bin Wang, Lulin Ma, Xiaojun Tian, Lijun Chen & Jinkai Dong. (2022) Hengli® Chinese Botulinum Toxin Type A for Treatment of Patients With Overactive Bladder: A Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled Trial. Frontiers in Pharmacology 13.
Crossref
Crossref
Nandhakumar S.Sugreevudu G.Harikrishnan N.. (2021) Formulation design and Evaluation of Extended-Release Tablets of Oxybutynin for Effective Management of Overactive Bladder Syndrome. Research Journal of Pharmacy and Technology, pages 6558-6564.
Crossref
Crossref
Shambe Mutungi, Jacqueline Parrish, Robert Maunder, May Alarab, Colleen D. McDermott, Nucelio Lemos & Danny Lovatsis. (2019) Is overactive bladder independently associated with anxiety?. International Urogynecology Journal 30:10, pages 1763-1769.
Crossref
Crossref
Jacobus A. Van Rensburg & Farzana Cassim. (2018) The Non-neurogenic Overactive Bladder: an Update. Current Obstetrics and Gynecology Reports 7:4, pages 139-145.
Crossref
Crossref
Kummeling MT, Dolmans VE, van Uhm JI, de Vries L, Groenendijk PM, van Koeveringe GA & Elzevier HW. (2018) Initial report on subtrigonal Botulinum toxin-A (BoNT-A) therapy for female patients with urethral instability - results of a pilot study. Urology & Nephrology Open Access Journal 6:2.
Crossref
Crossref
Salima Ismail, Emmanuel Chartier-Kastler, Marie-Aimée Perrouin-Verbe, Johan Rose-Dite-Modestine, Pierre Denys & Véronique Phé. (2017) Long-Term Functional Outcomes of S3 Sacral Neuromodulation for the Treatment of Idiopathic Overactive Bladder. Neuromodulation: Technology at the Neural Interface 20:8, pages 825-829.
Crossref
Crossref
Judy Yuen-man Siu. (2017) Coping with patients suffering from overactive bladder: experiences of family caregivers in Hong Kong. Health & Social Care in the Community 25:1, pages 83-91.
Crossref
Crossref
Judy Yuen-man Siu. (2016) Imprisoned in the Cultural Stereotypes of Overactive Bladder. Nursing Research 65:5, pages 352-361.
Crossref
Crossref
Satoru TAKAHASHI, Mineo TAKEI, Osamu NISHIZAWA, Osamu YAMAGUCHI, Kumiko KATO, Momokazu GOTOH, Yasukuni YOSHIMURA, Masami TAKEYAMA, Hideo OZAWA, Makoto SHIMADA, Tomonori YAMANISHI, Masaki YOSHIDA, Hikaru TOMOE, Osamu YOKOYAMA & Masayasu KOYAMA. (2016) Clinical Guideline for Female Lower Urinary Tract Symptoms. LUTS: Lower Urinary Tract Symptoms 8:1, pages 5-29.
Crossref
Crossref
Judy Yuen-man Siu. (2015) Communicating under medical patriarchy: gendered doctor-patient communication between female patients with overactive bladder and male urologists in Hong Kong. BMC Women's Health 15:1.
Crossref
Crossref
Judy Yuen-man Siu. (2015) Communicating with mismatch and tension: treatment provision experiences of primary care doctors treating patients with overactive bladder in Hong Kong. BMC Family Practice 16:1.
Crossref
Crossref
David Habashy, Giovanni Losco, Vincent Tse, Ruth Collins & Lewis Chan. (2015) Botulinum toxin (OnabotulinumtoxinA) in the male non-neurogenic overactive bladder: clinical and quality of life outcomes. BJU International 116, pages 61-65.
Crossref
Crossref
Judy Yuen-man Siu. (2014) "Seeing a doctor is just like having a date": a qualitative study on doctor shopping among overactive bladder patients in Hong Kong. BMC Family Practice 15:1.
Crossref
Crossref
Judy Yuen-man Siu. (2014) The Illness Experiences of Women with Overactive Bladder in Hong Kong. Qualitative Health Research 24:6, pages 801-810.
Crossref
Crossref
Christopher Chapple, Karl-Dietrich Sievert, Scott MacDiarmid, Vik Khullar, Piotr Radziszewski, Christopher Nardo, Catherine Thompson, Jihao Zhou & Cornelia Haag-Molkenteller. (2013) OnabotulinumtoxinA 100 U Significantly Improves All Idiopathic Overactive Bladder Symptoms and Quality of Life in Patients with Overactive Bladder and Urinary Incontinence: A Randomised, Double-Blind, Placebo-Controlled Trial. European Urology 64:2, pages 249-256.
Crossref
Crossref
Shannon HK Kim, David Habashy, Sana Pathan, Vincent Tse, Ruth Collins & Lewis Chan. (2006) Eight-Year Experience With Botulinum Toxin Type-A Injections for the Treatment of Nonneurogenic Overactive Bladder: Are Repeated Injections Worthwhile?. International Neurourology Journal 20:1, pages 40-46.
Crossref
Crossref